Impact of Aging on Oxysterol Regulation of Alveolar Macrophage Function during S. pneumoniae

衰老对肺炎链球菌期间肺泡巨噬细胞功能的氧甾醇调节的影响

基本信息

项目摘要

Project Abstract Normal lung aging is associated with multiple structural and functional changes in the respiratory tract. Alveolar macrophages (AM) are long-lived tissue resident innate immune cells of the airways and during steady state conditions, adopt a pro-healing, anti-inflammatory phenotype to maintain lung integrity. AM are key effectors of recognition, initiation, and resolution of the host defense against microbes and play an essential role in mediating host responses to Streptococcus pneumoniae (S. pne). Cell essential and macrophage aged death and the effective clearance of dying cells are processes t hat maintain tissue homeostasis. When efferocytosis is defective, increased tissue injury development of acute respiratory distress syndrome (ARDS) can occur. Despite defects in alveolar phagocytosis being prevalent i n aging, very little is known on how the process of aging and the lung microenvironment contribute to these changes.Our published findings illustrate that an age- associated increase in mitochondrial and endoplasmic reticulum stress during S. pne contributed to dysregulated, overly heightened pro-inflammatory immune responses in AM and lung. To better understand the metabolic factors that might contribute to this phenotype, we examined changes in lipid metabolism in young and aged lung. We observed a molecular reprogramming in response to dysregulated cholesterol homeostasis. Given these findings, we hypothesize that an age-associated increase in lipid metabolism alters innate immune responsiveness and efferocytosis by AMs, thereby contributing to heightened inflammation and prolonged tissue injury in response to S. pne. To test this hypothesis, we have designed three specific aims that will utilize innovative techniques to spatially landscape landscape the mediated utilize the will the resolve single-cell data that will allow us to develop a biologically interpretable of lung pathology from a structural, immunological, and clinical standpoint. This spatial single-cell will enable the pathophysiological characterization of the lung from its macroscopic presentation to single-cell, providing an important basis for the understanding of lipid metabolism on alveolar macrophage process and will provide insights into age-associated changes in lung pathology. In addition, we will metagenomic sequencing of human plasma to distinguish infection and infectious disease, and to assess severity of pneumococcal disease. We firmly believe that fundamental insights gained from this novel assay be applicable to other infection models and will help clarify many of the long-outstanding questions regarding role of aging on specific tissue responses.
项目摘要 正常的肺老化与呼吸道的多种结构和功能变化有关。肺泡 巨噬细胞(AM)是气道的长寿命组织驻留先天免疫细胞, 条件下,采用促愈合,抗炎表型,以保持肺的完整性。AM是 识别、启动和解决宿主对微生物的防御,并在介导 宿主对肺炎链球菌(S. pne)。细胞 基本 和 巨噬 岁 死亡和死亡细胞的有效清除, 维持组织内环境稳定的过程。当红细胞增多症有缺陷时, 可能发生急性呼吸窘迫综合征(ARDS)。尽管牙槽骨缺损 吞噬作用在衰老中普遍存在,但对衰老过程和吞噬作用如何发生知之甚少。 肺部微环境导致了这些变化。我们发表的研究结果表明,年龄- 相关的增加线粒体和内质网的压力,在S。PNE导致失调, AM和肺中过度增强的促炎免疫应答。为了更好地了解代谢 可能导致这种表型的因素,我们研究了年轻和老年人脂质代谢的变化, 肺。我们观察到一个分子重编程,以应对失调的胆固醇稳态。给定 根据这些发现,我们推测,与年龄相关的脂质代谢增加改变了先天免疫功能, 反应性和巨噬细胞增多,从而导致炎症加剧和组织延长, 损伤响应S. pne。为了验证这一假设,我们设计了三个具体的目标, 创新技术, 景观 景观 的 介导 利用 的 将 的 解析单细胞数据,这将使我们能够开发一种生物学上可解释的 从结构、免疫学和临床的角度来研究肺病理学。这种空间单细胞 将使肺的病理生理学表征从其宏观表现, 为了解肺泡巨噬细胞的脂质代谢提供了重要依据 过程,并将提供洞察与年龄相关的肺部病理变化。此外,我们将 人类血浆宏基因组测序,以区分感染和传染病,并评估 肺炎球菌疾病的严重程度。我们坚信,从这种新的分析中获得的基本见解 适用于其他感染模型,并将有助于澄清许多长期悬而未决的问题, 衰老对特定组织反应的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Heather Winona Stout Delgado其他文献

Heather Winona Stout Delgado的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Heather Winona Stout Delgado', 18)}}的其他基金

Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged Lung
UPR 激活增强对老年肺中流感和继发性肺炎链球菌感染炎症反应的影响
  • 批准号:
    10643784
  • 财政年份:
    2018
  • 资助金额:
    $ 65.99万
  • 项目类别:
Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged Lung
UPR 激活增强对老年肺中流感和继发性肺炎链球菌感染炎症反应的影响
  • 批准号:
    10401901
  • 财政年份:
    2018
  • 资助金额:
    $ 65.99万
  • 项目类别:
Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged Lung
UPR 激活增强对老年肺中流感和继发性肺炎链球菌感染炎症反应的影响
  • 批准号:
    10207433
  • 财政年份:
    2018
  • 资助金额:
    $ 65.99万
  • 项目类别:
Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged Lung
UPR 激活增强对老年肺中流感和继发性肺炎链球菌感染炎症反应的影响
  • 批准号:
    10161896
  • 财政年份:
    2018
  • 资助金额:
    $ 65.99万
  • 项目类别:
Impact of Heightened ER Stress on NLRP3 Activation in Aged Lung during Infection
感染期间内质网应激升高对老化肺 NLRP3 激活的影响
  • 批准号:
    10207384
  • 财政年份:
    2017
  • 资助金额:
    $ 65.99万
  • 项目类别:
Detection & Use of Novel Therapeutics to Stimulate NLRP3 Activity in the Elderly
检测
  • 批准号:
    8637399
  • 财政年份:
    2013
  • 资助金额:
    $ 65.99万
  • 项目类别:
Detection & Use of Novel Therapeutics to Stimulate NLRP3 Activity in the Elderly
检测
  • 批准号:
    8741915
  • 财政年份:
    2013
  • 资助金额:
    $ 65.99万
  • 项目类别:
Aging with Chronic Viral Infections and the Impact on Innate Immune Responses
慢性病毒感染引起的衰老及其对先天免疫反应的影响
  • 批准号:
    8510540
  • 财政年份:
    2011
  • 资助金额:
    $ 65.99万
  • 项目类别:
Aging with Chronic Viral Infections and the Impact on Innate Immune Responses
慢性病毒感染引起的衰老及其对先天免疫反应的影响
  • 批准号:
    8309075
  • 财政年份:
    2011
  • 资助金额:
    $ 65.99万
  • 项目类别:
Aging with Chronic Viral Infections and the Impact on Innate Immune Responses
慢性病毒感染引起的衰老及其对先天免疫反应的影响
  • 批准号:
    8897929
  • 财政年份:
    2011
  • 资助金额:
    $ 65.99万
  • 项目类别:

相似海外基金

Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.99万
  • 项目类别:
    Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
  • 批准号:
    10722669
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
  • 批准号:
    491387
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
    Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
  • 批准号:
    10678788
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
  • 批准号:
    10646578
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
  • 批准号:
    23K08447
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
  • 批准号:
    10601865
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
  • 批准号:
    23K08360
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
  • 批准号:
    10722194
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
  • 批准号:
    10594793
  • 财政年份:
    2023
  • 资助金额:
    $ 65.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了